Skip to content

Herbal Moxibustion in pelvic and sacral region for endometriosis: A single-center randomized contorlled trial

Herbal moxibustion in pelvic and sacral region for endometriosis: A randomized contorlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010326
Enrollment
Unknown
Registered
2017-01-04
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

Sponsors

The Third Affiliated Hospital of Zhejiang Chinese Meidcal University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients with ovarian endometriosis or ovarian endometriosis cyst diagnosed by gynecologists; 2. Aged 18-50 years old female patients; 3. Have a history of endometriosis for more than 6 months; 4. Have endometriosis related dysmenorrhea and pelvic pain symptoms for more than 6 months,and have endometriosis cyst,which diameter between 2-6cm by ultrasound examination(including recurrence endometriosis cyst after operation); 5. With regular menstrual cycle, with no pregnance plan during the period of treatment (6 months); 6. Patients agree to participte in this trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Who are preparing to pregnance, or get pregnant, or in lactating period, or in perimenopausal or postmenopausal period; 2. Patients who have received traditional Chinese medicine or acupuncture treatments in the last three months; 3. Patients with cicatricial diathesis, or shallow sensory disorder, or whose skin is easy to allergic to traditional Chinese medicine, or who can not tolerate the smell of smoke caused by moxa; 4. Patients who are unable to receive this treatment because of other major diseases or mental disorders; 5. Patients who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
VAS;

Secondary

MeasureTime frame
Quality of life;CA125;B ultrasound examination;

Countries

China

Contacts

Public ContactJianqiao Fang

The Third Affiliated Hospital of Zhejiang Chinese Meidcal University

707168423@qq.com+86 13605707532

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026